CFT7503

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCFT7503

Drug Alias NameCFT-7503

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionProteolysis

TargetsBromodomain-containing protein 9

Therapy Area/IndicationsSarcoma, Synovial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesC4 Therapeutics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSarcoma, Synovial

Inactive IndicationsN/A

ATC CodeN/A